Sound Pharmaceuticals concludes subject enrolment for SPI-1005 trial

​

Sound Pharmaceuticals has concluded subject enrolment for its second Phase III clinical trial assessing SPI-1005 in adults with probable or definite Meniere’s disease in the US.

The post Sound Pharmaceuticals concludes subject enrolment for SPI-1005 trial appeared first on Hospital Management.

 

Back to the Featured Stories
Sound Pharmaceuticals concludes subject enrolment for SPI-1005 trial

Featured Stories

FDA clears Medtronic’s LigaSure RAS Maryland device
SpliSense begins Phase IIb SPL84 trial for cystic fibrosis
Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy
Hyperfine concludes Contrast PMR study enrolment for Swoop MRI system
Arrowhead reports top-line results in mixed hyperlipidaemia trial

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us